Literature DB >> 16809331

Infection of naive target cells with virus-like particles: implications for the function of ebola virus VP24.

Thomas Hoenen1, Allison Groseth, Larissa Kolesnikova, Steven Theriault, Hideki Ebihara, Bettina Hartlieb, Sandra Bamberg, Heinz Feldmann, Ute Ströher, Stephan Becker.   

Abstract

Infectious virus-like particle (iVLP) systems have recently been established for several negative-strand RNA viruses, including the highly pathogenic Zaire ebolavirus (ZEBOV), and allow study of the viral life cycle under biosafety level 2 conditions. However, current systems depend on the expression of viral helper nucleocapsid proteins in target cells, thus making it impossible to determine whether ribonucleoprotein complexes transferred by iVLPs are able to facilitate initial transcription, an indispensable step in natural infection. Here we describe a ZEBOV iVLP system which overcomes this limitation and show that VP24 is essential for the formation of a functional ribonucleoprotein complex.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16809331      PMCID: PMC1489071          DOI: 10.1128/JVI.00051-06

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  19 in total

1.  Plasmid-driven formation of influenza virus-like particles.

Authors:  G Neumann; T Watanabe; Y Kawaoka
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

2.  Identification of the lymphocytic choriomeningitis virus (LCMV) proteins required to rescue LCMV RNA analogs into LCMV-like particles.

Authors:  Ki Jeong Lee; Mar Perez; Daniel D Pinschewer; Juan Carlos de la Torre
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

3.  Biochemical and functional characterization of the Ebola virus VP24 protein: implications for a role in virus assembly and budding.

Authors:  Ziying Han; Hani Boshra; J Oriol Sunyer; Susan H Zwiers; Jason Paragas; Ronald N Harty
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

4.  Generation of eGFP expressing recombinant Zaire ebolavirus for analysis of early pathogenesis events and high-throughput antiviral drug screening.

Authors:  Jonathan S Towner; Jason Paragas; Jason E Dover; Manisha Gupta; Cynthia S Goldsmith; John W Huggins; Stuart T Nichol
Journal:  Virology       Date:  2005-02-05       Impact factor: 3.616

5.  Formation of virus-like particles from cloned cDNAs of Thogoto virus.

Authors:  Elke Wagner; Othmar G Engelhardt; Friedemann Weber; Otto Haller; Georg Kochs
Journal:  J Gen Virol       Date:  2000-12       Impact factor: 3.891

6.  Replication and amplification of novel vesicular stomatitis virus minigenomes encoding viral structural proteins.

Authors:  E A Stillman; J K Rose; M A Whitt
Journal:  J Virol       Date:  1995-05       Impact factor: 5.103

7.  Comparison of the transcription and replication strategies of marburg virus and Ebola virus by using artificial replication systems.

Authors:  E Mühlberger; M Weik; V E Volchkov; H D Klenk; S Becker
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

8.  Efficient recovery of infectious vesicular stomatitis virus entirely from cDNA clones.

Authors:  S P Whelan; L A Ball; J N Barr; G T Wertz
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-29       Impact factor: 11.205

9.  Production of novel ebola virus-like particles from cDNAs: an alternative to ebola virus generation by reverse genetics.

Authors:  Shinji Watanabe; Tokiko Watanabe; Takeshi Noda; Ayato Takada; Heinz Feldmann; Luke D Jasenosky; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

10.  The assembly of Ebola virus nucleocapsid requires virion-associated proteins 35 and 24 and posttranslational modification of nucleoprotein.

Authors:  Yue Huang; Ling Xu; Yongnian Sun; Gary J Nabel
Journal:  Mol Cell       Date:  2002-08       Impact factor: 17.970

View more
  58 in total

1.  Viral and host proteins that modulate filovirus budding.

Authors:  Yuliang Liu; Ronald N Harty
Journal:  Future Virol       Date:  2010-07-01       Impact factor: 1.831

2.  Identification of essential filovirion-associated host factors by serial proteomic analysis and RNAi screen.

Authors:  Kevin B Spurgers; Tim Alefantis; Brian D Peyser; Gordon T Ruthel; Alison A Bergeron; Julie A Costantino; Sven Enterlein; Krishna P Kota; R C Dutch Boltz; M Javad Aman; Vito G Delvecchio; Sina Bavari
Journal:  Mol Cell Proteomics       Date:  2010-08-11       Impact factor: 5.911

3.  Oligomerization of Ebola virus VP40 is essential for particle morphogenesis and regulation of viral transcription.

Authors:  T Hoenen; N Biedenkopf; F Zielecki; S Jung; A Groseth; H Feldmann; S Becker
Journal:  J Virol       Date:  2010-05-12       Impact factor: 5.103

4.  Regulation of VP30-Dependent Transcription by RNA Sequence and Structure in the Genomic Ebola Virus Promoter.

Authors:  Simone Bach; Jana-Christin Demper; Arnold Grünweller; Stephan Becker; Nadine Biedenkopf; Roland K Hartmann
Journal:  J Virol       Date:  2020-12-02       Impact factor: 5.103

5.  Crystal structure of the C-terminal domain of Ebola virus VP30 reveals a role in transcription and nucleocapsid association.

Authors:  Bettina Hartlieb; Tadeusz Muziol; Winfried Weissenhorn; Stephan Becker
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-03       Impact factor: 11.205

6.  Filovirus replication and transcription.

Authors:  Elke Mühlberger
Journal:  Future Virol       Date:  2007-03       Impact factor: 1.831

7.  RNA Binding of Ebola Virus VP30 Is Essential for Activating Viral Transcription.

Authors:  Nadine Biedenkopf; Julia Schlereth; Arnold Grünweller; Stephan Becker; Roland K Hartmann
Journal:  J Virol       Date:  2016-07-27       Impact factor: 5.103

8.  Role of Ebola virus VP30 in transcription reinitiation.

Authors:  Miguel J Martínez; Nadine Biedenkopf; Valentina Volchkova; Bettina Hartlieb; Nathalie Alazard-Dany; Olivier Reynard; Stephan Becker; Viktor Volchkov
Journal:  J Virol       Date:  2008-10-01       Impact factor: 5.103

9.  Enhanced protection against Ebola virus mediated by an improved adenovirus-based vaccine.

Authors:  Jason S Richardson; Michel K Yao; Kaylie N Tran; Maria A Croyle; James E Strong; Heinz Feldmann; Gary P Kobinger
Journal:  PLoS One       Date:  2009-04-23       Impact factor: 3.240

10.  Marburg virus evades interferon responses by a mechanism distinct from ebola virus.

Authors:  Charalampos Valmas; Melanie N Grosch; Michael Schümann; Judith Olejnik; Osvaldo Martinez; Sonja M Best; Verena Krähling; Christopher F Basler; Elke Mühlberger
Journal:  PLoS Pathog       Date:  2010-01-15       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.